Teaching Session 2020
RT is considered/offered to all those with residual craniopharngioma post surgery. It may also be used in recurrent tumours, if not used previously. The efficacy is outlined in the case series below.
Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
Semi B Harrabi, Sebastian Adeberg, Thomas Welzel, Stefan Rieken, Daniel Habermehl, Jürgen Debus and Stephanie E Combs
Radiation Oncology 2014, 9:203
Long term follow up of the series of 55 patients treated with fractionated stereotactic radiotherapy by Stephanie Combs